MarketLens
Sign Up

What's Driving Tyra Biosciences' Recent Surge

7 months ago
SHARE THIS ON:

What's Driving Tyra Biosciences' Recent Surge

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•3 days ago

ImmunityBio Stock Jumps: What's Going On?

ImmunityBio (IBRX) shares jumped Friday, extending a multi-month uptrend, though no specific catalyst was cited in the snippet.
Stock News•3 weeks ago

Why Is Tyra Biosciences Stock Sinking Wednesday?

Tyra Biosciences (NASDAQ:TYRA) shares fell Wednesday after the company reported initial Phase 2 SURF302 results for oral dabogratinib, which delivered clinical proof of concept and identified a 60 mg ...
Stock News•1 months ago

SYRE Rallies 44.9% in 3 Months. Can Clinical Catalysts Sustain It?

Spyre (SYRE) rallied 44.9% in 3 months, driven by positive ulcerative colitis data and 2026 clinical catalysts. Its elevated valuation raises the stakes for upcoming readouts, which could determine wh...

Breaking News

View All →

Top Headlines

View More →
Stock News•2 hours ago

Forget the S&P 500: SCHD Is Beating It by Nearly 10 Points in 2026 and Its Dividend Just Grew

Stock News•4 hours ago

NVDY: NVIDIA Shares Break To Record Highs, Don't Cede The Upside Now

Stock News•6 hours ago

Is Copilot Microsoft's Secret Weapon in the AI Arms Race?

Stock News•7 hours ago

2 Millionaire-Maker Quantum Computing Stocks to Buy Hand Over Fist

Stock News•7 hours ago

The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It